Ambalal Sarabhai Enterprises Ltd.

View in App
46.60 -0.71 ▼-1.5%

23 April 2024, 04:01:00 PM
Volume: 74,875

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ase.life
Market Cap 357.72 Cr.
Enterprise Value(EV) 378.12 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.38 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 123.99 Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 16.72 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.79 Calculated using Price: 46.68
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 7.66 Cr. 76,633,296 Shares
FaceValue 10
About Ambalal Sarabhai Enterprises Ltd.
Ambalal Sarabhai Enterprises is a Baroda-based pharmaceutical manufacturing company which was incorporated in 1977. It is one of the company belonging to the Sarabhai Group. The Group's principal activity is manufacture and marketing of pharmaceutical products and bulk drugs. The company's plants are located at Vadodara and Ahmedabad.

Ambalal Sarabhai Enterprises Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Ambalal Sarabhai Enterprises Ltd. Performance

View details >>
1 Day
-1.50%
1 Week
-2.98%
1 Month
-1.15%
3 Month
-11.49%
6 Month
+12.42%
1 Year
+115.44%
2 Year
+29.99%
5 Year
+226.33%
10 Year
+1606.96%

Ambalal Sarabhai Enterprises Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 328.25 -57.92 4.2 7.01 40.95 49.47 48.74 8.85
Return on Capital Employed (%) 10.08 107.14 -11.94 16.34 13.17 27.14 40.28 45.53 11.08
Return on Assets (%) -3.51 25.83 -10.3 0.62 0.99 7.84 15.02 21.57 4.67

Ambalal Sarabhai Enterprises Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -9 39 25 27 31 45 74 120 131 127
Non Curr. Liab. 15 13 6 11 9 5 5 5 20 13
Curr. Liab. 163 153 124 155 171 133 129 105 95 101
Minority Int. 0 0 0 0 0 0
Equity & Liab. 169 204 155 193 211 183 208 230 246 240
Non Curr. Assets 100 92 82 80 95 79 87 110 129 130
Curr. Assets 68 112 73 114 116 104 121 120 117 110
Misc. Exp. not W/O
Total Assets 169 204 155 193 211 183 208 230 246 240

Ambalal Sarabhai Enterprises Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 125 132 134 125 152 134 164 197 170 164
Other Income 13 95 6 25 5 24 31 42 12 10
Total Income 137 227 140 150 157 158 194 239 183 174
Total Expenditure -129 -145 -145 -137 -146 -135 -165 -172 -161 -160
PBIDT 9 82 -5 13 11 22 29 67 21 14
Interest -10 -4 -5 -3 -3 -4 -3 -2 -3 -4
Depreciation -5 -17 -4 -2 -2 -3 -2 -2 -3 -4
Taxation -1 -14 -5 -7 -4 -1 -3 -7 -4 -3
Exceptional Items -15
PAT -7 48 -19 1 2 15 29 47 11 3
Minority Interest
Share Associate 0 0 2 -1 0
Other Related Items
Consolidated Net Profit -7 48 -18 1 4 14 29 47 11 3
Adjusted EPS -1 6 -2 0 1 2 4 6 1 0

Ambalal Sarabhai Enterprises Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 11 -8 -75 5 -7 19 -7 -2 11 6
Cash Fr. Inv. -1 10 80 -3 18 -9 17 10 5 -17
Cash Fr. Finan. -8 -1 -3 -6 -2 -6 -14 -6 -19 9
Net Change 2 1 2 -4 8 3 -4 2 -3 -2
Cash & Cash Eqvt 8 8 10 5 14 17 13 15 12 10

Ambalal Sarabhai Enterprises Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 30.76 30.76 30.76 30.77 30.77 30.77 30.77 30.77 30.77
Public 69.24 69.24 69.24 69.23 69.23 69.23 69.23 69.23 69.23
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Ambalal Sarabhai Enterprises Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations 2015 For The Financial Year Ended 31St March 2024.
We hereby submit Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations 2015 for the financial year ended 31.03.2024.Kindly take the same on your records.
Mon, 15 Apr 2024
Compliance Certificate Under Regulation 40(9) And 40(10) Of SEBI (LODR) Regulations 2015
We hereby submit compliance certificate pursuant to regulation 40(9) and 40(10) of SEBI (LODR) Regulations 2015 the certificate received from M/s. RPSS & Co. PCS firm Ahmedabad for the year ended 31.03.2024.Please take the same on your records.
Fri, 12 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations 2015 we would like to inform you that the RTA of the Company MCS Share Transfer Agent Limited has received request from Shareholder for issue of Letter of Confirmation (Duplicate Share Certificates).Kindly take the same on your records.

Ambalal Sarabhai Enterprises Ltd. Technical Scans

View details >>
Tue, 23 Apr 2024
High Increase in 1 Year High Increase in 1 Year
High Increase in 5 Years High Increase in 5 Years
MFI Trending Down MFI Trending Down
Mon, 22 Apr 2024
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Decrease in 3 Months High Decrease in 3 Months

Ambalal Sarabhai Enterprises Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Ambalal Sarabhai Enterprises Ltd. FAQ's

What is Ambalal Sarabhai Ent share price?
Can I buy Ambalal Sarabhai Ent shares now?
What is the Market Cap of Ambalal Sarabhai Ent?
What are the key metrics to analyse Ambalal Sarabhai Ent?
What is the 52 Week High and Low of Ambalal Sarabhai Ent?
What is the trend of Ambalal Sarabhai Ent share price?